These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20426701)

  • 1. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease.
    Rodriguez-Iturbe B; Correa-Rotter R
    Expert Opin Pharmacother; 2010 Nov; 11(16):2687-98. PubMed ID: 20426701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Background of measures against chronic kidney disease].
    Hishida A
    Nihon Rinsho; 2008 Sep; 66(9):1639-44. PubMed ID: 18788388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette use and cardiovascular risk in chronic kidney disease: an unappreciated modifiable lifestyle risk factor.
    Stack AG; Murthy BV
    Semin Dial; 2010; 23(3):298-305. PubMed ID: 20636923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic kidney disease. Better detect, slow its progression and cardiovascular risk, prepare for renal replacement therapy].
    Legendre C
    Rev Prat; 2012 Jan; 62(1):27-9. PubMed ID: 22335062
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dyslipidemia as a therapeutic target for prevention of cardiovascular events and end-stage renal disease].
    Watanabe T
    Nihon Rinsho; 2008 Sep; 66(9):1761-9. PubMed ID: 18788407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of CKD in Japan].
    Iseki K
    Nihon Rinsho; 2008 Sep; 66(9):1650-6. PubMed ID: 18788390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of cardiovascular risk factors in chronic renal disease.
    Coresh J; Longenecker JC; Miller ER; Young HJ; Klag MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S24-30. PubMed ID: 11443765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease and cardiovascular disease: a case presentation.
    McCarley PB; Salai PB
    Nephrol Nurs J; 2007; 34(2):187-98; quiz 199-200. PubMed ID: 17486949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease.
    Peralta CA; Shlipak MG; Fan D; Ordoñez J; Lash JP; Chertow GM; Go AS
    J Am Soc Nephrol; 2006 Oct; 17(10):2892-9. PubMed ID: 16959827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
    Brandenburg V; Floege J
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():158-62. PubMed ID: 16802544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Integrated care and expected outcomes over the progression of CKD (chronic kidney disease)].
    Kimura G
    Nihon Rinsho; 2008 Sep; 66(9):1807-13. PubMed ID: 18788414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease in older people; disease or dilemma?
    Ahmed AK; Brown SH; Abdelhafiz AH
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):835-41. PubMed ID: 20814116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in patients with chronic kidney disease: why, who and when?
    Gluba A; Rysz J; Banach M
    Expert Opin Pharmacother; 2010 Nov; 11(16):2665-74. PubMed ID: 20977401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure.
    Baber U; Toto RD; de Lemos JA
    Am Heart J; 2007 Apr; 153(4):471-7. PubMed ID: 17383281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.